|
Bronx Hospitals Lead Nationwide Investigative Drug Trial For Severe Lung Inflammation From COVID-19 https://www.norwoodnews.org/bronx-hospitals-lead-nationwide-… Seethamraju said that the Leronlimab trial is different from the remdesivir drug trial in that remdesivir cannot be given to patients with renal and liver damage, but leronlimab can. |
|
| aus der Diskussion: | CytoDyn $CYDY mit Blockbuster Potential WKN: A0YHA5 |
| Autor (Datum des Eintrages): | Xarope (23.05.20 17:06:28) |
| Beitrag: | 9,901 von 30,091 (ID:63780334) |
| Alle Angaben ohne Gewähr © wallstreetONLINE | |